You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

HETERO LABS LTD III Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for HETERO LABS LTD III, and what generic and branded alternatives to HETERO LABS LTD III drugs are available?

HETERO LABS LTD III has seventy approved drugs.

There are three tentative approvals on HETERO LABS LTD III drugs.

Summary for HETERO LABS LTD III

US Patents:	0
Tradenames:	59
Ingredients:	58
NDAs:	70

Drugs and US Patents for HETERO LABS LTD III

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hetero Labs Ltd Iii	NEBIVOLOL HYDROCHLORIDE	nebivolol hydrochloride	TABLET;ORAL	203825-004	Nov 3, 2020	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Hetero Labs Ltd Iii	ESCITALOPRAM OXALATE	escitalopram oxalate	SOLUTION;ORAL	202221-001	Jun 12, 2012	AA	RX	No	Yes		⤷ Sign Up				⤷ Sign Up
Hetero Labs Ltd Iii	DABIGATRAN ETEXILATE MESYLATE	dabigatran etexilate mesylate	CAPSULE;ORAL	207961-002	May 6, 2020	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Hetero Labs Ltd Iii	HYDRALAZINE HYDROCHLORIDE	hydralazine hydrochloride	TABLET;ORAL	040901-003	Sep 12, 2008	AA	RX	No	No		⤷ Sign Up				⤷ Sign Up
Hetero Labs Ltd Iii	FENOFIBRATE	fenofibrate	TABLET;ORAL	204598-001	Jul 12, 2016	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for HETERO LABS LTD III drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.